BBLG
Bone Biologics Corp
NASDAQ: BBLG · HEALTHCARE · BIOTECHNOLOGY
$1.31
+0.38% today
Updated 2026-04-30
Market cap
$2.44M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.65
Dividend yield
—
52W range
$1 – $7
Volume
0.0M
Bone Biologics Corp (BBLG) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-24326.00 | $-4871.00 | $-45451.00 | $-5681.00 | $-447.00 | $-6116.00 | $-2.76M | $-3.55M | $-7.33M | $-3.33M | $-4.10M | $-3.25M | $-426933.00 | $-1.23M | $-3.57M | $-9.56M | $-4.12M | $-2.69M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $11901.00 | $504.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $5.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | $256642.00 | $3.70M | $3.46M | $-584027.00 | $516638.00 | $49692.00 | $60000.00 | $207035.00 | $266633.00 | $152599.00 | $188819.00 | $256358.00 |
| Free cash flow | $-24326.00 | $-4871.00 | $-45451.00 | $-5681.00 | $-447.00 | $-6116.00 | $-2.77M | $-3.55M | $-7.33M | $-3.33M | $-4.10M | $-3.25M | $-426933.00 | $-1.23M | $-3.57M | $-9.56M | $-4.12M | $-2.69M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | $3.21M | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | $-24145.00 | — | — | — | — | — |